Cargando…

Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis

Hydroxyurea has long been used for the treatment of sickle cell anemia (SCA), and its clinical effectiveness is related to the induction of fetal hemoglobin (HbF), a major modifier of SCA phenotypes. However, there is substantial variability in response to hydroxyurea among patients with SCA. While...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sales, Rahyssa Rodrigues, Nogueira, Bárbara Lisboa, Tosatti, Jéssica Abdo Gonçalves, Gomes, Karina Braga, Luizon, Marcelo Rizzatti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814522/ https://www.ncbi.nlm.nih.gov/pubmed/35126118 http://dx.doi.org/10.3389/fphar.2021.779497

Ejemplares similares

Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes
por: Steinberg, Martin H.
Publicado: (2020)

Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients
por: Kargutkar, Neha, et al.
Publicado: (2023)

miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia
por: Cyrus, Cyril, et al.
Publicado: (2022)

CNTO 530 Increases Expression of HbA and HbF in Murine Models of β-Thalassemia and Sickle Cell Anemia
por: Makropoulos, Dorie A, et al.
Publicado: (2013)

Genetic variants at HbF‐modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania
por: Mtatiro, Siana Nkya, et al.
Publicado: (2014)

Combined approaches for increasing fetal hemoglobin (HbF) and de novo production of adult hemoglobin (HbA) in erythroid cells from β-thalassemia patients: treatment with HbF inducers and CRISPR-Cas9 based genome editing
por: Finotti, Alessia, et al.
Publicado: (2023)

A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction
por: Zuccato, Cristina, et al.
Publicado: (2012)

Whole Exome Sequencing Identifies Novel Genes for Fetal Hemoglobin Response to Hydroxyurea in Children with Sickle Cell Anemia
por: Sheehan, Vivien A., et al.
Publicado: (2014)

Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia
por: Fitzhugh, Courtney D., et al.
Publicado: (2015)

The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers
por: Zuccato, Cristina, et al.
Publicado: (2023)

The Effect of Alpha Thalassemia, HbF and HbC on Haematological Parameters of Sickle Cell Disease Patients in Ibadan, Nigeria
por: Fasola, Foluke Atinuke, et al.
Publicado: (2022)

FOETAL HAEMOGLOBIN (HbF) STATUS IN ADULT SICKLE CELL ANAEMIA PATIENTS IN IBADAN, NIGERIA
por: Olaniyi, J.A., et al.
Publicado: (2010)

P-028: CIRCULATING CD34+CD235A+ CELL COUNT CORRELATES WITH LEVELS OF HBF IN SICKLE CELL ANEMIA PATIENTS UNDER HYDROXYUREA TREATMENT
por: J., MILHOMENS, et al.
Publicado: (2022)

Candidate Sequence Variants and Fetal Hemoglobin in Children with Sickle Cell Disease Treated with Hydroxyurea
por: Green, Nancy S., et al.
Publicado: (2013)

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
por: Allard, Pierre, et al.
Publicado: (2021)

Fetal hemoglobin and hemolysis markers in sickle cell anemia()
por: Colella, Marina Pereira, et al.
Publicado: (2015)

Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh
por: Bhagat, Sanjana, et al.
Publicado: (2012)

Pattern of hemolysis parameters and association with fetal hemoglobin in sickle cell anemia patients in steady state
por: Moreira, Juliane Almeida, et al.
Publicado: (2015)

P1437: ASSESSING THE ROLE OF MICRORNAS IN HYDROXYUREA -MEDIATED HBF INDUCTION IN HAEMOGLOBINOPATHIES PATIENTS
por: Kargutkar, Neha, et al.
Publicado: (2023)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

HbF Levels in Sickle Cell Disease Are Associated with Proportion of Circulating Hematopoietic Stem and Progenitor Cells and CC-Chemokines
por: Minniti, Caterina P., et al.
Publicado: (2020)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia
por: Keikhaei, Bijan, et al.
Publicado: (2016)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia
por: Eridani, Sandro, et al.
Publicado: (2011)

Association of polymorphisms in the HBG1‐HBD intergenic region with HbF levels
por: Hu, Li, et al.
Publicado: (2020)

Genome Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania
por: Mtatiro, Siana Nkya, et al.
Publicado: (2014)

Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia
por: Silva, Danilo Grunig Humberto, et al.
Publicado: (2013)

Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
por: Queiroz, Ana Mach, et al.
Publicado: (2021)

Intensive hydroxyurea dosing in very young children with sickle cell anemia
por: Wang, Winfred C., et al.
Publicado: (2023)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
por: da Silva, Luiz Bernardino Lima, et al.
Publicado: (2012)

Very mild forms of Hb S/beta(+)-thalassemia in Brazilian children
por: Belisário, André Rolim, et al.
Publicado: (2015)

Genetic Variation on Chromosome 6 Influences F Cell Levels in Healthy Individuals of African Descent and HbF Levels in Sickle Cell Patients
por: Creary, Lisa E., et al.
Publicado: (2009)

Comment on "The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea"
por: Souza, José Carlos, et al.
Publicado: (2012)

Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study
por: Kaddam, Lamis, et al.
Publicado: (2015)

Unique Polymorphisms at BCL11A, HBS1L-MYB and HBB Loci Associated with HbF in Kuwaiti Patients with Sickle Cell Disease
por: Akbulut-Jeradi, Nagihan, et al.
Publicado: (2021)

Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review
por: dos Santos Neres, Joelma Santana, et al.
Publicado: (2023)

Sickle Cell Disease and Fetal Hemoglobin
por: Rivera, Alicia
Publicado: (2018)

Influence of βS-globin haplotypes hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia
por: Laurentino, Marília Rocha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ij5upoukq3i8qt9g0jian48ui5